Neurologix, Inc. $35M (MarketCap) Releases Successful Phase 2 Trial of Gene Therapy for Parkinson’s Disease

Neurologix, Inc. M (MarketCap) Releases Successful Phase 2 Trial of Gene Therapy for Parkinson’s Disease Parkinson’s disease is a progressive and debilitating neurodegenerative disorder that arises from the gradual deterioration of nerve cells in the brain. It affects the control of bodily movement and is characterized by four principal symptoms: limb tremor, limb rigidity, bradykinesia […]

Autologous Neural Stem Cells Benefit Parkinson’s Patients

Autologous Neural Stem Cells Benefit Parkinson’s Patients Stem cells and stem cell research have long been studied to help provide relief of symptoms and potential cures for neurodegenerative diseases such as Parkinson’s disease. The use of adult stem cell therapy has grown in popularity, surpassing even traditional embryonic stem cell research methodology is. Autologous stem […]